A Randomized, Double-blind, Placebo-controlled, Proof-of-concept Study Assessing the Efficacy and Safety of an Anti-TNF-OX40L NANOBODY^® Molecule, SAR442970, in Participants With Moderate-to-severe Hidradenitis Suppurativa (HS OBTAIN)

A Parallel-group Treatment, Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAR444656 (KT-474) in Adult Participants With Moderate-to-severe Hidradenitis Suppurativa (ZEN)

A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel-group, Proof-of-concept Study Assessing the Efficacy and Safety of Amlitelimab in Adult Participants With Moderate-to-severe Hidradenitis Suppurativa